Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS

Clinical trial NCT06598202 · RECRUITING

Trial details

NCT number: NCT06598202
Sponsor: Xuanwu Hospital, Beijing
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2024-12-01
Primary completion: 2026-05-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.